🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

148,46 USD

Máx. histórico

156,92

14 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,39%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,24%

Cierre anterior

150,33

Rango de hoy

146,28 – 149,59

Volumen hoy

10.884.998

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
118,77 (puede no estar actualizado)
Dividend yield
2,26% (puede no estar actualizado)
Precio objetivo analistas
150,42 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 4 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,26%
Fecha de pago Importe por participación
31/05/2000 0,2767 USD
01/03/2000 0,2767 USD
01/12/1999 0,2767 USD
01/09/1999 0,2767 USD
02/06/1999 0,2576 USD
03/03/1999 0,2576 USD
02/12/1998 0,2576 USD
02/09/1998 0,2576 USD
03/06/1998 0,2147 USD
04/03/1998 0,2147 USD
03/12/1997 0,2147 USD
03/09/1997 0,2147 USD
05/06/1997 0,2004 USD
05/03/1997 0,2004 USD
05/12/1996 0,1908 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/02/1995 18,91 18,96 18,85 18,96 +0,00% 0,63% 4.101.243
01/02/1995 19,20 19,20 18,85 18,96 -1,24% 1,86% 7.059.538
31/01/1995 18,73 19,26 18,67 19,20 +2,88% 3,18% 11.634.267
30/01/1995 18,43 18,79 18,37 18,67 +0,97% 2,27% 5.413.339
27/01/1995 18,49 18,55 18,25 18,49 +0,32% 1,61% 4.844.694
26/01/1995 18,13 18,49 18,13 18,43 +1,31% 1,97% 4.581.856
25/01/1995 17,89 18,31 17,89 18,19 +0,99% 2,33% 4.140.019
24/01/1995 17,89 18,25 17,83 18,01 -0,33% 2,33% 4.598.624
23/01/1995 17,83 18,19 17,83 18,07 +0,33% 2,01% 4.127.443
20/01/1995 18,13 18,25 17,95 18,01 -0,98% 1,64% 6.938.598
19/01/1995 18,25 18,37 18,13 18,19 -0,97% 1,31% 2.957.666
18/01/1995 18,19 18,49 18,19 18,37 +0,00% 1,64% 5.072.949
17/01/1995 18,19 18,37 18,13 18,37 +0,65% 1,31% 4.016.355
16/01/1995 18,01 18,37 18,01 18,25 +0,99% 1,99% 5.350.040
13/01/1995 17,65 18,13 17,59 18,07 +2,71% 3,04% 5.010.278
12/01/1995 17,77 17,89 17,59 17,59 -1,67% 1,68% 3.760.434
11/01/1995 17,47 17,89 17,35 17,89 +2,74% 3,07% 5.387.139
10/01/1995 17,59 17,65 17,35 17,41 -0,68% 1,69% 6.382.320
09/01/1995 17,77 17,89 17,53 17,53 -2,00% 2,01% 5.727.110
06/01/1995 18,01 18,07 17,83 17,89 -0,66% 1,32% 3.417.738
05/01/1995 18,13 18,19 18,01 18,01 -0,98% 0,99% 2.865.022
04/01/1995 18,25 18,31 18,07 18,19 -0,33% 1,31% 4.402.229
03/01/1995 18,13 18,43 18,07 18,25 +0,33% 1,97% 5.817.029
30/12/1994 18,49 18,55 18,19 18,19 -1,29% 1,94% 3.576.614
29/12/1994 18,61 18,61 18,43 18,43 -0,96% 0,96% 3.137.083
28/12/1994 18,67 18,73 18,55 18,61 -0,95% 0,96% 3.332.221
27/12/1994 18,73 18,85 18,67 18,79 +0,32% 0,96% 3.526.310
23/12/1994 18,61 18,79 18,55 18,73 +0,96% 1,28% 3.590.867
22/12/1994 18,67 18,79 18,49 18,55 -0,64% 1,60% 4.509.334
21/12/1994 18,43 18,79 18,43 18,67 +1,29% 1,94% 8.021.392